Case report
An 83 year-old female patient was admitted for several occasions in our institution during the year of 2008 for chronic diarrhea. At first presentation she reported five to seven bowel movements per day, sometimes with bloody stools. These complaints were accompanied by loss of appetite, weight loss and malaise. Laboratory data: leucocytes 4000 mL, hemoglobin 11.4 g/dL, VGM 89.2 fL, creatinine 89 mmol/L, blood urea nitrogen 3.6 mmol/L; Na+ 144 mmol/L; K+ 2.9 mmol/L, total serum proteins 50 g/L, albumin 20 g/L, CRP 171 mg/L.
A colonoscopy was performed, disclosing exuberant mucosal adherent plaques throughout the entire colon suggesting pseudomembranous colitis (Fig. 1) . The patient was started on oral vancomycin 125 mg qid for seven days with favourable clinical response.
After this admission, the patient was admitted five times further with multiple bowel movements of foul-smelling stools and fever. During these admissions she underwent several courses of treatment with metronidazole, vancomycin and probiotics, always with successive recurrences. Since clinical symptoms were persistent and associated with endoscopic typical findings and important analytical disturbances, it was made the diagnostic of chronic refractory Clostridium difficile-associated colitis. In face of these facts, it was decided to initiate perfusion of immunoglobulins 400 mg/Kg associated with prolonged oral vancomycin treatment. The patient has since then been asymptomatic.
Discussion
Clostridium difficile is a gram positive bacillus first described in 1935, responsible for a specific type of diarrhea-pseudomembranous colitis.
In recent years, a more virulent strain classified as NAP1/ B1/027 has been identified and it has been held responsible for Clostridium difficile-associated diarrhea breakthroughs with higher morbidity and mortality (2) . Three factors are important for this bacterial virulence: a higher production of specific A and B toxins, resistance to fluoroquinolones and production of a binary toxin (2) . The risk of recurrence after a first episode has been estimated as 20% and this figure may reach 40% after a first recurrence. Recurrence may be explained by re-infection with different strain or by persistence of bacteria after the first acute episode (2). Hypoalbuminemia and previous therapeutic failure of metronidazole are associated with recurrences (3), as was seen with our case.
The mortality rate associated with Clostridium difficile-associated diarrhea raised in the USA between 1999 and 2004 from 5.7 to 23.7 per million individuals (3) . Is has been stated that resistant strains are due to indiscriminate use of antibiotics, mainly fluoroquinolones, cephalosporins and penicilins. The incorrect use of antibiotics will thus have its impact on hospital admission rates, mortality rate and higher costs with diagnostic examinations and treatments. 
